Press Releases

Polyplus-transfection SA, a privately-held company specializing in the development of innovative solutions for transfection, today announces the launch of FectoPRO(TM), the latest optimised transfection reagent in their product portfolio. FectoPRO has been designed for high yields in medium and...

Domain Therapeutics, a biopharmaceutical company specializing in the research and development of new drug candidates targeting G protein-coupled receptors (GPCRs), today announces the nomination of Dr Youssef L. Bennani to the board of directors. Following this nomination, Youssef L....

MENLO PARK, Calif. – February 18, 2014 – SRI International today announced the availability of its FASTcell™ technology offered as a testing service for detecting and characterizing rare circulating tumor cells (CTCs) from whole blood samples. The technology can...

Executive With 25 Years’ Experience of Successful Life Science Commercialisation To Lead DNA Electronics’ Evolution From Licensing House To Product Business. London, UK, 8th May 2014. – DNA Electronics Ltd, a provider of point-of-care genomic diagnostics...

Top industry players, European Commission representatives, the WHO, the Innovative Medicine Initiative, the European Institute of Innovation and Technology and Chinese delegations will participate Biovision’s ninth edition will take place in Lyon, France on June 5 and 6, 2014...

Telstar has enhanced its global activities in engineering and construction for local and multinational pharmaceutical companies The ability to offer comprehensive high-technology solutions in engineering, construction and process equipment for the life sciences market has led...

DNA Electronics Ltd (DNAe), a developer of semiconductor solutions for real-time DNA and RNA detection, today announces that it had successfully secured the necessary funding for DNAe to develop the Genalysis® point-of-care genomic diagnostic product line. The majority of...